Technical Evaluation Reference Group (TERG) is an independent evaluation advisory group, accountable to the Board of The Global Fund to Fight AIDS, Tuberculosis & Malaria for ensuring independent evaluation of the Global Fund business model, investments and impact.
The TERG oversees independent evaluations on behalf of the Board and its Committees. It also oversees the evaluation functions performed by the Secretariat and advises the Global Fund Secretariat on evaluation approaches and practices, independence, reporting procedures and other technical and managerial aspects of monitoring and evaluation at all levels.
Membership of the TERG is drawn from a range of stakeholders, including practitioners, research institutions, academics, from donor and recipient countries, and non-governmental organizations. Members of the TERG are appointed by the Board of the Global Fund. They serve in their personal capacities, do not represent their employers, governments or organizations and institutionally independent of the Secretariat, the Board and Board Committees.
The TERG is chaired by Dr Mickey Chopra, Chief of Health at UNICEF.
The TERG Vice-Chairs are Dr Wim Van Damme, Professor of Public Health and Health Policy at the Institute of Tropical Medicine, Antwerp, Belgium, and Dr Viroj Tangcharoensathien, Director of the International Health Policy Program, at the Ministry of Public Health of Thailand.
From 2007-2009, the TERG provided oversight for the Five-Year Evaluation and presented the final report, the synthesis report [ PDF - 1 MBEnglish ], to the Global Fund Board at the 19th Board meeting in May 2009.
The TERG has significantly contributed to the Global Fund’s Evaluation Strategy for 2012-2016 and will support the Ten-Year evaluation of the Global Fund.
The Impact and Evaluation Team of the IRE Department of the Global Fund Secretariat work in collaboration with TERG in achieving joint objectives.
TERG Terms of Reference
[PDF - 36 KB]
Contact | Report Fraud and Abuse | Legal | RSS | Sitemap
© 2014 The Global Fund to Fight AIDS, Tuberculosis and Malaria